Results 201 to 210 of about 78,803 (280)

Acute Pancreatitis Associated with Propofol in a Patient with End-Stage Renal Disease: Diagnostic Challenges and Confounding Factors. [PDF]

J Pharm Technol
Itzayana Guadalupe WR, Francisco Javier AG, Silvia RM, Susanna Edith MG, Juan Manuel MN, Lucila Isabel CP, Rosa Del Carmen MS.   +6 more
europepmc   +1 more source

Metrnl as a predictive biomarker for postprandial hypertriglyceridemia in overweight and obese populations. [PDF]

Front Endocrinol (Lausanne)
Wang X, Tang Y, Zeng S, Li L, Hou Y, Liu D, Tian P, Song G.   +7 more
europepmc   +1 more source

Lipodystrophies in Clinical Practice: A Case Series From a Local Health Unit in Portugal. [PDF]

Cureus
Barbosa R, Pinheiro AT, Borges T, Silva ES, Silva JD, Soares AR, Carvalho R, Fonseca L.   +7 more
europepmc   +1 more source

Efficacy and safety of small interfering RNA (siRNA) therapies for hypertriglyceridemia and mixed dyslipidemia: an updated systematic review and meta-analysis. [PDF]

Front Pharmacol
Gao Y, Bai Y, Mu X, Pang X.
europepmc   +1 more source

Chronically elevated sympathetic nervous system tone: A significant, common, and poorly realised contributor to cardiometabolic disease in type 2 diabetes

Diabetes, Obesity and Metabolism, Volume 28, Issue 3, Page 1595-1598, March 2026.
Ralph A. DeFronzo
wiley   +1 more source

Refractory Severe Hypertriglyceridemia With Insulin Resistance Treated by Early Therapeutic Plasma Exchange: A Case Report and Review of the Literature. [PDF]

Cureus
Bedi A, Kermanshah A, Bedi S, Kalaydjian G.   +3 more
europepmc   +1 more source

Atherogenic Dyslipidemia in Children and Adolescents: Current Evidence, Clinical Challenges, and Future Perspectives. [PDF]

J Cardiovasc Dev Dis
Giussani M, Casula M, Orlando A, Parati G, Genovesi S.   +4 more
europepmc   +1 more source

The influence of midlife morbidity clusters on dementia risk: The ARIC study. [PDF]

Alzheimers Dement
Kinyanjui E, Groechel RC, Morrill V, Walker KA, Kucharska-Newton AM, Mosley TH, Koton S, Knopman DS, Weiss J, Gottesman RF, Egle M.   +10 more
europepmc   +1 more source

Lorlatinib atypical safety profile in ALK-positive aNSCLC: tips for management from an Italian expert panel. [PDF]

Future Oncol
Ardizzoni A, Cortinovis D, Gori B, Nuzzo A, Pasello G, de Marinis F.   +5 more
europepmc   +1 more source